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Abstract— Cells are the smallest living units of living 
system. Stem cells are undifferentiated biological 
cells that can differentiate into specialized cells and 
can divide to produce more stem cells. Embryonic stem 
(ES) cells are the inner cell mass of a blastocyst, an early-
stage embryo. (Thomson et al., 1998). ES cells 
are pluripotent and give rise during development to all 
derivatives of the three primary germ layers: ectoderm, 
endoderm and mesoderm. Adult stem cells, also 
called somatic stem cells, they are stem cells which 
maintain and repair the tissue in which they are found 
(Behrens et al., 2014). Pluripotent adult stem cells are 
rare and generally small in number, but they can be found 
in umbilical cord blood and other tissues. Embryonic 
stem cells can be grown relatively easily in culture. Adult 
stem cells are rare in mature tissues. Cell potency is 
a cell's ability to differentiate into other cell types. Stem 
cells resembling totipotent blastomeres from 2-cell stage 
embryos can arise spontaneously in the embryonic stem 
cell cultures. (Macfarlan et al., 2012). New research 
related to multipotent cells suggests that multipotent cells 
may be capable of conversion into unrelated cell types. In 
one case, fibroblasts were converted into functional 
neurons. Stem-cell therapy is the use of stem cells to treat 
or prevent a disease or condition. 
Keywords— Stem cell, Types, Identification, Properties, 
Cell potency, Stem cell therapy, Medical use. 
 
I. INTRODUCTION 
Stem cells are a pervasive component of embryonic and 
foetal development, tissue maintenance and of 
regeneration and repair. Stem cells are potential source of 
new cells for the therapeutic regeneration of diseased or 
damaged tissue. Embryonic Stem cells are pluripotent and 
have retained their embryonic capacity to give rise to 
most, probably all, cell types. The potential advantage of 
ES cells is their ability to be isolated and grown in large 
numbers coupled with their ability to differentiate into 
any other cell of the body. Tissue transplantation carries 
with it the risk of immune reaction and rejection unless 
the donor cells are closely immunologically matched or 
(ideally) identical to those of the patient. One seductively 
enticing scenario would be to provide a source of ES 
cells, genetically identical to the patient from which that 
required specialised pre- cursor cells might be 
differentiated. This would involve “de-differentiation” of 
a cell from the patient to an ES state. The only method so 
far known to work in animal model experiments is 
nuclear transplantation into an oocyte and establishment 
of the ES cell line from the early embryo formed. Such 
somatic cell nuclear transfer (SCNT) technique could be 
used to generate a patient speciﬁc ES cell line. This 
scenario of generating an embryo by nuclear transfer of 
an adult cell nucleus into an enucleated oocyte, making an 
ES cell line and using this to generate cells which will 
repopulate tissues of an adult, has been fully 
demonstrated in a mouse model. 
 
Stem Cell 
Stem cells are undifferentiated biological cells that 
can differentiate into specialized cells and 
can divide (through mitosis) to produce more stem cells. 
They are found in multicellular organisms. In mammals, 
there are two broad types of stem cells: embryonic stem 
cells, which are isolated from the inner cell 
mass of blastocysts, and adult stem cells, which are found 
in various tissues. In adult organisms, stem cells 
and progenitor cells act as a repair system for the body, 
replenishing adult tissues. In a developing embryo, stem 
cells can differentiate into all the specialized cells 
ectoderm, endoderm and mesoderm but also maintain the 
normal turnover of regenerative organs, such as blood, 
skin, or intestinal tissues.  
 Stem cells are distinguished from other cell types 
by two important characteristics. First, they are 
unspecialized cells capable of renewing themselves 
through cell division, sometimes after long periods of 
inactivity. Second, under certain physiologic or 
experimental conditions, they can be induced to become 
tissue or organ-specific cells with special functions. 
 
History of stem cell   
In the mid 1800s it was discovered that cells were 
basically the building blocks of life and that some cells 
had the ability to produce other cells. In 1968, the first 
bone marrow transplant was performed to successfully 
treat two siblings with severe combined 
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immunodeficiency. Other key events in stem cell research 
include: 
1978: Stem cells were discovered in human cord blood 
1981: First in vitro stem cell line developed from mice 
1988: Embryonic stem cell lines created from a hamster 
1995: First embryonic stem cell line derived from a 
primate 
1997: Cloned lamb from stem cells 
1997: Leukaemia origin found as haematopoietic stem 
cell, indicating possible proof of cancer stem cells. 
 
Properties of all stem cells 
Stem have three general properties:  
They are capable of dividing and renewing themselves for 
long periods, they are unspecialized and they can give rise 
to specialized cell types.  
 
Embryonic stem cells  
Embryonic stem (ES) cells are the cells of the inner cell 
mass of a blastocyst, an early-stage embryo. Thomson et 
al., (1998). ES cells are pluripotent and give rise during 
development to all derivatives of the three primary germ 
layers: ectoderm, endoderm and mesoderm. During 
embryonic development these inner cell mass cells 
continuously divide and become more specialized.  
 
Embryonic stem cells grown in the laboratory   
Growing cells in the laboratory is known as cell culture. 
Embryonic stem cells are generated by transferring cells 
from a pre-implantation stage embryo into a plastic 
laboratory culture dish that contains a nutrient broth 
known as culture medium. The cells divide and spread 
over the surface of the dish. The inner surface of the 
culture dish is typically coated with mouse embryonic 
skin cells that have been treated so they will not divide. 
This coating layer of cells is called a feeder layer. The 
mouse cells in the bottom of the culture dish provide the 
cells a sticky surface to which they can attach. Also, the 
feeder cells release nutrients into the culture medium. 
Researchers have devised ways to grow embryonic stem 
cells without mouse feeder cells. This is a significant 
scientific advance because of the risk that viruses or other 
macromolecules in the mouse cells may be transmitted to 
the human cells.  
The process of generating an embryonic stem cell line is 
somewhat inefficient, so lines are not produced each time 
cells from the pre-implantation-stage embryo are placed 
into a culture dish. However, if the plated cells survive, 
divide, and multiply enough to crowd the dish, they are 
removed gently and plated into several fresh culture 
dishes. The process of re-plating or sub-culturing the cells 
is repeated many times and for many months. Each cycle 
of sub-culturing the cells is referred to as a passage. Once 
the cell line is established, the original cells yield millions 
of embryonic stem cells. Embryonic stem cells that have 
proliferated in cell culture for six or more months without 
differentiating, are pluripotent, and appear genetically 
normal are referred to as an embryonic stem cell line. At 
any stage in the process, batches of cells can be frozen 
and shipped to other laboratories for further culture and 
experimentation. 
 
Laboratory tests are used to identify embryonic stem 
cells  
However, laboratories that grow human embryonic stem 
cell lines use several kinds of tests, including:  
1. Growing and sub-culturing the stem cells for many 
months. This ensures that the cells are capable of 
long-term growth and self- renewal.  
2. Using specific techniques to determine the 
presence of transcription factors that are typically 
produced by undifferentiated cells. Two of the 
most important transcription factors are Nanog and 
Oct 4.  
3. Using specific techniques to determine the 
presence of particular cell surface markers that are 
typically produced by undifferentiated cells. 
4. Examining the chromosomes under a microscope. 
This is a method to assess whether the 
chromosomes are damaged or if the number of 
chromosomes has changed. It does not detect  
genetic mutations in the cells.  
5. Determining whether the cells can be re-grown, or 
sub-cultured, after freezing, thawing, and re-
plating.  
6. Testing whether the human embryonic stem cells 
are pluripotent by allowing the cells to 
differentiate spontaneously in cell culture, 
manipulating the cells so they will differentiate to 
form  cells characteristic of the three germ layers 
and injecting the cells into a mouse with a 
suppressed immune system to test for the 
formation of a benign tumor called a teratoma. 
 
Adult stem cells 
Adult stem cells, also called somatic stem cells, they are 
stem cells which maintain and repair the tissue in which 
they are found. Pluripotent adult stem cells are rare and 
generally small in number, but they can be found in 
umbilical cord blood and other tissues. (Ratajczak et al., 
2007). Bone marrow is a rich source of adult stem 
cells, which have been used in treating several conditions 
including liver cirrhosis, chronic limb ischemia and end 
stage heart failure.  
Adult stem cells are also used in veterinary medicine to 
treat tendon and ligament injuries in horses. The history 
 International Journal of Environment, Agriculture and Biotechnology (IJEAB)                           Vol-2, Issue-5, Sep-Oct- 2017 
http://dx.doi.org/10.22161/ijeab/2.5.51                                                                                                                   ISSN:  2456-1878 
www.ijeab.com                                                                                                                                                                           Page | 2681 
of research on adult stem cells began about 50 years ago. 
In the 1950s, researchers discovered that the bone marrow 
contains at least two kinds of stem cells. One population, 
called hematopoietic stem cells, forms all the types of 
blood cells in the body. A second population, called bone 
marrow stromal stem cells (also called mesenchymal stem 
cells, or skeletal stem cells by some) were discovered a 
few years later.  
 
Identification and function of stem cells 
Adult stem cells have been identified in many organs and 
tissues, including brain, bone marrow, peripheral blood, 
blood vessels, skeletal muscle, skin, teeth, heart, gut, 
liver, ovarian epithelium, and testis. They are thought to 
reside in a specific area of each tissue (called a “stem cell 
niche”). In many tissues, current evidence suggests that 
some types of stem cells are pericytes, cells that compose 
the outermost layer of small blood vessels. Stem cells 
may remain quiescent (non-dividing) for long periods of 
time until they are activated by a normal need for more 
cells to maintain tissues, or by disease or tissue injury.  
 
Tests are used to identify adult stem cells 
Scientists often use one or more of the following methods 
to identify adult stem cells: 
(1) Label the cells in a living tissue with molecular 
markers and then determine the specialized cell types 
they generate. 
(2) Remove the cells from a living animal, label them in 
cell culture, and transplant them back into another 
animal to determine whether the cells replace (or 
“repopulate”) their tissue of origin.  
 
Adult stem cell differentiation 
Normal differentiation pathways of adult stem cells. In a 
living animal, adult stem cells are available to divide for a 
long period, when needed, and can give rise to mature cell 
types that have characteristic shapes and specialized 
structures and functions of a particular tissue. 
1. Hematopoietic stem cells:-Hematopoietic stem 
cell give rise to all the types of blood cells. 
2. Mesenchymal stem cells:-Mesenchymal stem 
cell have been reported to be present in many 
tissues.  
3. Neural stem cells:-Neural stem cells in the brain 
give rise to its three major cell types: nerve cells 
(neurons). 
4. Epithelial stem cells:-Epithelial stem cell in the 
lining of the digestive tract occur in deep crypts 
and  give rise to several cell types: absorptive 
cells, goblet cells, Paneth cells, and 
enteroendocrine cells. 
5. Skin stem cells:-Skin stem cells occur in the 
basal layer of the epidermis and at the base of 
hair follicles. 
 
Differences between embryonic and adult stem cells 
One major difference between adult and embryonic stem 
cells is their different abilities in the number and type of 
differentiated cell types they can become. Embryonic 
stem cells can become all cell types of the body because 
they are pluripotent. Adult stem cells are thought to be 
limited to differentiating into different cell types of their 
tissue of origin. Embryonic stem cells can be grown 
relatively easily in culture. Adult stem cells are rare in 
mature tissues, so isolating these cells from an adult tissue 
is challenging.  
 
Cell Potency 
Cell potency is a cell's ability to differentiate into other 
cell types. The more cell types a cell can differentiate 
into, the greater its potency. Potency is taken from the 
Latin term "potens" which means "having power." 
 
Totipotency 
Totipotency is the ability of a single cell to divide and 
produce all of the differentiated cells in 
an organism. Spores and zygotesare examples of 
totipotent cells. Toti comes from the Latin totus which 
means "entirely". Stem cells resembling totipotent 
blastomeres from 2-cell stage embryos can arise 
spontaneously in the embryonic stem cell cultures. 
(Macfarlan et al., 2012). and also can be induced to arise 
more frequently in vitro through down-regulation of the 
chromatin assembly activity of CAF-1.  
 
Pluripotency 
Pluripotency (from the Latin plurimus, meaning very 
many, and potens, meaning having power) refers to a stem 
cell that has the potential to differentiate into any of the 
three germ layers: endoderm, mesoderm or ectoderm and 
nervous system. 
 
Induced pluripotency 
Induced pluripotent stem cells, commonly abbreviated as 
iPS cells or iPSCs are a type of pluripotent stem 
cell artificially derived from a non-pluripotent cell, 
typically an adult somatic cell, by inducing a "forced" 
expression of certain genes and transcription factors. 
These transcription factors play a key role in determining 
the state of these cells and also highlight the fact that 
these somatic cells do preserve the same genetic 
information as early embryonic cells. (Stadtfeld and 
Hochedlinger 2010). The ability to induce cells into a 
pluripotent state was initially pioneered in 2006 using 
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mouse fibroblasts and four transcription factors, Oct4, 
Sox2, Klf4 and c-Myc; this technique, called 
reprogramming, earned Shinya Yamanaka and John 
Gurdon the Nobel Prize in Physiology or Medicine 2012.  
 
Multipotency 
Multipotency describes progenitor cells which have the 
gene activation potential to differentiate into multiple, but 
limited cell types. New research related to multipotent 
cells suggests that multipotent cells may be capable of 
conversion into unrelated cell types. In one case, 
fibroblasts were converted into functional neurons. 
(Vierbuchen et al., 2010). Multipotent cells are found in 
many, but not all human cell types. Multipotent cells have 
been found in cord blood, (Yong and Theodore 
2010). Adipose tissue, cardiac cells, bone marrow, 
and mesenchymal stem cells (MSCs) which are found in 
the third molar. Hematopoietic stem cells are an example 
of multipotency.  
 
Oligopotency 
Oligopotency is the ability of progenitor cells to 
differentiate into a few cell types. It is a degree 
of potency. Examples of oligopotent stem cells are the 
lymphoid or myeloid stem cells.  
 
Unipotency 
A unipotent cell is the concept that one stem cell has the 
capacity to differentiate into only one cell type. 
 
Stem cell therapy 
Stem-cell therapy is the use of stem cells to treat or 
prevent a disease or condition: Bone marrow transplant is 
the most widely used stem-cell therapy, but some 
therapies derived from umbilical cord blood are also in 
use. Research is underway to develop various sources for 
stem cells, and to apply stem-cell treatments 
for neurodegenerative diseases and conditions such 
as diabetes, heart disease, and other conditions. 
 
Medical uses 
For over 30 years, bone marrow has been used to treat 
cancer patients with conditions such 
as leukaemia and lymphoma; this is the only form of 
stem-cell therapy that is widely practiced. (Karanes et al., 
2008).  Another stem-cell therapy called Prochymal, was 
conditionally approved in Canada in 2012 for the 
management of acute graft vs host disease in children 
who are unresponsive to steroids. It is an allogenic stem 
therapy based on mesenchymal stem cells (MSCs) 
derived from the bone marrow of adult donors. 
 
Neuro-degeneration 
Research has been conducted on the effects of stem cells 
on animal models of brain degeneration, such as 
in Parkinson's, Amyotrophic lateral sclerosis, 
and Alzheimer's disease. There have been preliminary 
studies related to multiple sclerosis.  
 
Heart 
Possible mechanisms of recovery include:  
Generation of heart muscle cells, stimulation of growth of 
new blood vessels to repopulate damaged heart tissue, 
secretion of growth factors and assistance via some other 
mechanism. 
Wound healing 
Stem cells can also be used to stimulate the growth of 
human tissues. In an adult, wounded tissue is most often 
replaced by scar tissue, which is characterized in the skin 
by disorganized collagen structure, loss of hair follicles 
and irregular vascular structure.  
 
Infertility 
Culture of human embryonic stem cells in mitotically 
inactivated porcine ovarian fibroblasts (POF) causes 
differentiation into germ cells (precursor cells of oocytes 
and spermatozoa), as evidenced by gene 
expression analysis. (Richards et al., 2008). The stem cell, 
therapy may also be used in the treatment of the 
following: Brain and spinal cord injury, Blood cell 
formation, Missing teeth, Cochlear hair cell re-growth, 
Blindness and vision impairment, Pancreatic beta cell, 
Orthopaedics etc. 
 
Veterinary medicine 
Research currently conducted on horses, dogs, and cats 
can benefit the development of stem cell treatments in 
veterinary medicine and can target a wide  range of 
injuries and diseases such as myocardial infarction, 
stroke, tendon and ligament damage, osteoarthritis, osteoc
hondrosis and muscular dystrophy both in large animals, 
as well as humans. (Murphy et al., 2003).  
 
Sources of stem cells 
Veterinary applications of stem cell therapy as a means of 
tissue regeneration have been largely shaped by research 
that began with the use of adult-derived mesenchymal 
stem cells to treat animals with injuries or defects 
affecting bone, cartilage, ligaments and/or tendons. There 
are two main categories of stem cells used for treatments: 
allogeneic stem cells derived from a genetically different 
donor within the same species 
and autologous mesenchymal stem cells, derived from the 
patient prior to use in various treatments. A third 
category, xenogenic stem cells, or stem cells derived from 
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different species, are used primarily for research 
purposes, especially for human treatments.  
 
Stem cells and hard-tissue repair 
Because of the general positive healing capabilities of 
stem cells, they have gained interest for the treatment of 
cutaneous wounds. In one trial, stem cells were isolated 
from the Wharton's jelly of the umbilical cord. These cells 
were injected directly into the wounds. Within a week, 
full re-epithelialization of the wounds had occurred, 
compared to minor re-epithelialization in the control 
wounds. This showed the capabilities of mesenchymal 
stem cells in the repair of epidermal tissues.        
                                                                       
Stem cells and orthopaedic repairs                                                                                                    
Logous stem cell-based treatments 
for ligament injury, tendon injury, osteoarthritis, osteocho
ndrosis, and sub-Auto-chondral bone cysts have been 
commercially available to practicing veterinarians to treat 
horses since 2003 in the United States and since 2006 in 
the United Kingdom. Autologous stem cell based 
treatments for tendon injury, ligament injury, 
and osteoarthritis in dogs have been available to 
veterinarians in the United States since 2005. Over 3000 
privately owned horses and dogs have been treated with 
autologous adipose-derived stem cells. The efficacy of 
these treatments has been shown in double-blind clinical 
trials for dogs with osteoarthritis of the hip and elbow and 
horses with tendon damage. (Nixon et al., 2008).   
 
Tendon repair 
The embryonic stem cells were shown to have a better 
survival rate in the tendon as well as better migrating 
capabilities to reach all areas of damaged tendon. The 
overall repair quality was also higher, with better tendon 
architecture and collagen formed.  
 
Joint repair  
Horses and dogs are most frequently affected arthritis. 
Adipose-derived mesenchymal cells are currently the 
most often used because of the non-invasive harvesting. 
There has been a lot of success recently injecting 
mesenchymal stem cells directly into the joint. This is a 
recently developed, non-invasive technique developed for 
easier clinical use. Dogs receiving this treatment showed 
greater flexibility in their joints and less pain. (Guercio  et 
al., 2012).  
 
Bone defect repair 
Stem cells have been used to treat degenerative bone 
diseases. The normally recommended treatment for dogs 
that have Legg Calve Perthes disease. Recently, 
mesenchymal stem cells have been injected directly in to 
the head of the femur, with success not only in bone 
regeneration, but also in pain reduction.  
 
Stem cells and muscle repairs 
Stem cells have successfully been used to ameliorate 
healing in the heart after myocardial infarction in dogs. 
Adipose and bone marrow derived stem cells were 
removed and induced to a cardiac cell fate before being 
injected into the heart. The heart was found to have 
improved contractility and a reduction in the damaged 
area four weeks after the stem cells were applied.  
 
Stem cells and nervous system repairs 
Spinal cord injuries are one of the most common traumas 
brought into veterinary hospitals. Mesenchymal stem cells 
that are induced to a neural cell fate are loaded on to a 
porous scaffold and are then implanted at the site of 
injury. The cells and scaffold secrete factors that 
counteract those secreted by scar forming cells and 
promote neural regeneration. Eight weeks later, dogs 
treated with stem cells showed immense improvement 
over those treated with conventional therapies. Dogs 
treated with stem cells were able to occasionally support 
their own weight, which has not been seen in dogs 
undergoing conventional therapies. (Sung Su Park et al., 
2012).  
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